Highlights
1 patentProfile claimed by owner
About
Genome Editing for Living Organisms
TargetGene Biotechnologies is an innovative and agile biotechnology company in its development stage and poised for expansion. The companys R&D is centered around creating efficient and extremely specific DNA editing solutions in living organisms. Through its patented and patent-pending TGEE (genome editing engine) platform, TargetGene has developed RNA-guided gene targeting. The company aims to implement the TGEE platform for human gene therapy with a focus on inherited diseases and cell-based immunotherapy.
Identity
| Name | TargetGene Biotechnologies |
|---|---|
| Slug | targetgene |
| Type / kind | startup |
| Crunchbase ID | targetgene-biotechnologies |
| Source _id | agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICAgMG6-JIKDA |
Status
| Status | active |
|---|---|
| Last update | 2026-05-17 |
Location
| HQ country code | IL |
|---|---|
| HQ region/district | Center District |
| HQ city | Rehovot |
| HQ address | Prof. Hillel ve-Khanan Oppenheimer St 10, Rehovot, Israel |
Web & social
| Website | https://targetgenebio.com |
|---|---|
| Careers page | https://targetgenebio.com/careers |
| https://www.linkedin.com/company/3216766 | |
| YouTube | https://www.youtube.com/channel/UCfX49fh4T07F1Of1m1BLVnw |
Classifications
Primary sector Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesPharma & Medical BiotechnologyDrugs Discovery & Development
Technologies
BiologicalsGenes
Target customers
Healthcare & Life SciencesLife SciencesBiotechnology
Business models
B2B
Tags
laboratoriesmedical-technologiesbiotechnologygenomicsgenetic-engineeringacademiageneticspatent-pending
Funding
| Total raised | $9.2M |
|---|---|
| Current stage | Series B |
Raw source document
Show full JSON (0 KB)
{
"0": "s",
"1": "l",
"2": "i",
"3": "m",
"4": "p",
"5": "a",
"6": "g",
"7": "e",
"8": "s",
"9": "_",
"10": "i",
"11": "m",
"12": "p",
"13": "o",
"14": "r",
"15": "t"
}